All articles by Andy Extance – Page 10
-
ResearchComputer reconstruction gives microscopy 100-fold precision boost
Confocal microscopy enhancement costing just a few dollars per image could be applied to all imaging
-
ResearchFirst liquid MOF could get material discovery flowing
Data and modelling show framework and porous structure are retained after melting
-
FeatureThe rising tide of 'legal highs'
Andy Extance investigates the chemistry that has helped recreational drugs evade the law, and its consequences
-
NewsNitrous oxide causes UK drug law confusion
Successful defences based on laughing gas’ medical uses follow prominent convictions that have resulted in a legal lottery
-
ResearchChemists find the σ-hole reason gold catalysts work
Calculations show low electron density makes nanoparticle corners and edges reactive
-
ResearchStructural sleuthing salvages superbug slayer
Combining ‘assembly line’ synthesis, spectroscopy and computational predictions solves stereochemistry riddle
-
BusinessGSK stops over 30 research programmes to prioritise innovation
New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects
-
BusinessAstraZeneca shares tumble after antibody failure
Imfinzi and tremelimumab checkpoint inhibitor pairing fails to beat chemotherapy in lung cancer
-
BusinessNovartis coasts towards first CAR-T approval
Unanimous recommendation for CTL019 ahead of October decision builds confidence in T-cell genetic reprogramming
-
ResearchSaturn ring-like ‘streaming’ takes liquids into a new world
Equatorial rings that break up into uniform microdroplets could be an alternative to microfluidic emulsification techniques
-
CareersWould you rent your lab equipment?
Virtual sharing and equopment loans are making access to vital research tools easier
-
ResearchEnergy storage prices forecast to tumble
First broad ‘evidence-based’ comparison shows similar capital cost evolution among technologies including lithium-ion and flow batteries
-
ResearchChemists unravel why humans aren’t constantly bursting into flames
Strong π-bonding holds the secret to taming dioxygen diradicals
-
ResearchLilly pushes continuous drug production limits
Integrated flow synthesis and purification process for prexasertib meets high industry standards
-
ResearchScientists get charged up over titanium dioxide
Groups debate usefulness of conventional +4 titanium oxidation state compared to +2.5 charge state
-
BusinessFirst biomarker-driven approval exemplifies cancer immunotherapy progress
Landmark decision is latest step in field’s impressive – but not wholly untroubled – advance
-
ResearchStick-up experiment lets scientists 'see' hydrogen atoms
Upright structures offer hard-to-get direct AFM measurements
-
BusinessMerck KGaA to buy Chematica
Retrosynthesis tool will gain computational muscle and integrate with Sigma–Aldrich catalogue
-
BusinessBrexit raises regulatory worries
Risk of doubling legal burden for industry undermines referendum’s ‘red-tape cutting’ claims
-
FeatureCovalent inhibitor drugs
Exceptions to a long-held rule against chemically bonding to biological targets are powering new cancer medicines, finds Andy Extance